Login / Signup

Bempedoic Acid: A New Drug for an Old Problem.

Dat NguyenNathan DuElisabeth M SulaicaMatthew A Wanat
Published in: The Annals of pharmacotherapy (2020)
The recent FDA approval of bempedoic acid offers an additional option for lowering LDL-C levels in patients with atherosclerotic cardiovascular disease or heterozygous familial hyperlipidemia. Additional data regarding effect on long-term cardiovascular outcomes with bempedoic acid are currently being studied.
Keyphrases
  • cardiovascular disease
  • type diabetes
  • emergency department
  • electronic health record
  • high fat diet
  • metabolic syndrome
  • machine learning
  • adipose tissue
  • cardiovascular events